Posaconazole-induced podocyte phospholipidosis
Kidney Int
.
2022 Mar;101(3):654.
doi: 10.1016/j.kint.2021.08.004.
Authors
Sarwat Gilani
1
,
Samih H Nasr
1
,
Sanjeev Sethi
2
Affiliations
1
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
2
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: sethi.sanjeev@mayo.edu.
PMID:
35190046
DOI:
10.1016/j.kint.2021.08.004
No abstract available
Publication types
Case Reports
MeSH terms
Humans
Lipidoses* / chemically induced
Podocytes*
Triazoles / adverse effects
Substances
Triazoles
posaconazole